Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED)

Clinical trial NCT00718237 · COMPLETED

Trial details

NCT number: NCT00718237
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rotavirus Gastroenteritis

Start date: 2008-08-01
Primary completion: 2009-08-01
Enrollment: 762

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.